Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.

about

Senescent cells re-engineered to express soluble programmed death receptor-1 for inhibiting programmed death receptor-1/programmed death ligand-1 as a vaccination approach against breast cancer.Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy

P2860

Q55442759-BAC3C437-FB83-49D6-92C6-EF7E0E9BF0B0 Q57492118-5EB4878B-8F1D-4A35-9D26-EABF170F4C68

P2860

Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.

Item

http://www.wikidata.org/entity/Q49387538

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Design and immunological evalu ...... anoparticulate cancer vaccine.

@en

Design and immunological evalu ...... anoparticulate cancer vaccine.

@nl

type

Item

label

Design and immunological evalu ...... anoparticulate cancer vaccine.

@en

Design and immunological evalu ...... anoparticulate cancer vaccine.

@nl

prefLabel

Design and immunological evalu ...... anoparticulate cancer vaccine.

@en

Design and immunological evalu ...... anoparticulate cancer vaccine.

@nl

P1476

Design and immunological evalu ...... anoparticulate cancer vaccine.

@en

P2093

Sams Ma Sadat

http://www.w3.org/2001/XMLSchema#string

Sheikh Tasnim Jahan

http://www.w3.org/2001/XMLSchema#string

P2860

Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading

Nanoparticulate adjuvants and delivery systems for allergen immunotherapy

Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy

Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.

Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.

Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.

Stepwise maturation of lytic granules during differentiation and activation of human CD8+ T lymphocytes.

Immature, but not inactive: the tolerogenic function of immature dendritic cells.

Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.

Preparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profiling.

P304

367-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S144266

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Azita Haddadi

P577

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29391795

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

P932

5768188

http://www.w3.org/2001/XMLSchema#string

Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.

about

P2860

P2860

Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932